Indicaton

Tisotumab vedotin (TV) is an investigational antibody-drug conjugate (ADC) designed to target the Tissue Factor antigen and is being developed in cervical cancer as well as other solid tumors.

Therapeutic indications
Type of product
Table
  • Phase
    Phase II started
  • Partnering status
    Partnered
  • Partner
    Genmab A/S